DrugPatentWatch Database Preview
AMABELZ Drug Profile
When do Amabelz patents expire, and what generic alternatives are available?
Amabelz is a drug marketed by Lupin Ltd and is included in one NDA.
The generic ingredient in AMABELZ is estradiol; norethindrone acetate. There are seventy-five drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the estradiol; norethindrone acetate profile page.
Summary for AMABELZ
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 3 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for AMABELZ |
| DailyMed Link: | AMABELZ at DailyMed |
Pharmacology for AMABELZ
| Ingredient-type | Estradiol Congeners Progesterone Congeners |
| Drug Class | Estrogen Progestin |
| Mechanism of Action | Estrogen Receptor Agonists |
US Patents and Regulatory Information for AMABELZ
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin Ltd | AMABELZ | estradiol; norethindrone acetate | TABLET;ORAL | 203339-001 | Jun 20, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Lupin Ltd | AMABELZ | estradiol; norethindrone acetate | TABLET;ORAL | 203339-002 | Jun 20, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
